C12N 2770/36222
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2770/36222 (New viral proteins or individual genes, new structural or functional aspects of) appears on 27 US grants and 23 published applications in this corpus.
Search patents in C12N- Granted patents
- 27
- Published applications
- 23
- Assignees
- 22
- Inventors
- 60
- Latest grant
- 17 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 2 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 3 | 0 |
| 1996 | 3 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 2 | 0 |
| 2001 | 2 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 6 |
| 2004 | 0 | 1 |
| 2005 | 1 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 1 | 1 |
| 2009 | 2 | 3 |
| 2010 | 0 | 3 |
| 2011 | 2 | 1 |
| 2012 | 1 | 0 |
| 2013 | 2 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 1 | 3 |
| 2022 | 0 | 0 |
| 2023 | 2 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 0 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Transient expression of biologic materials17 Mar 2026US 12,576,041 B1
- Rubella virus spike construct10 Oct 2023US 11,780,884 B2Institut Virion \ Serion GmbH
- Optically controlled virus protein, gene thereof, and virus vector containing said gene12 Sep 2023US 11,753,448 B2The University of Tokyo
- Identification and attenuation of the immunosuppressive domains in fusion proteins of enveloped RNA viruses30 Mar 2021US 10,961,279 B2ISD Immunotech ApS
- Rubella E1 envelope protein variants and their use in detection of anti-rubella antibodies8 Oct 2013US 8,551,696 B2Roche Diagnostics Operations, Inc.
- Identification and Attenuation of the Immunosuppressive Domains in Fusion Proteins of Enveloped RNA Viruses9 May 2024US 2024/0150409 A1ISD Immunotech ApS
- Rubella virus spike construct26 Aug 2021US 2021/0261624 A1Institut Virion \ Serion GmbH
- Identification and Attenuation of the Immunosuppressive Domains in Fusion Proteins of Enveloped RNA Viruses8 Jul 2021US 2021/0206812 A1ISD Immunotech ApS
- Optically controlled virus protein, gene thereof, and virus vector containing said gene25 Mar 2021US 2021/0087234 A1The University of Tokyo
- Identification and Attenuation of the Immunosuppressive Domains in Fusion Proteins of Enveloped RNA Viruses15 Dec 2016US 2016/0362454 A1Skau Aps
Most cited
By later US patents
- Baculovirus dual promoter expression vector44US 5,169,784 AThe Texas A&M University System · 1992
- Peptides representing epitopic sites for bacterial and viral meningitis causing agents and their CNS carrier and uses thereof40US 5,556,757 AInsight Biotek, Inc. · 1996
- Screening method for chronic immune dysfunction syndrome35US 5,426,028 ARush-Presbyterian-St. Luke's Medical Center · 1995
- Screening kit and method for diagnosing chronic immune dysfunction syndrome34US 5,538,856 AThe Regents of the University of California · 1996
- P-selectin ligand protein21US 7,563,760 B2Genetics Institute, Inc. · 2009